NABsys Revenue and Competitors
Estimated Revenue & Valuation
- NABsys's estimated annual revenue is currently $2.8M per year.
- NABsys's estimated revenue per employee is $63,409
- NABsys's total funding is $145M.
Employee Data
- NABsys has 44 Employees.
- NABsys grew their employee count by 52% last year.
NABsys's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Chief Technology Office | Reveal Email/Phone |
3 | Chief Commercial Officer | Reveal Email/Phone |
4 | EVP Product Development | Reveal Email/Phone |
5 | VP, Commercial Development | Reveal Email/Phone |
6 | VP Software & Informatics | Reveal Email/Phone |
7 | Associate Director | Reveal Email/Phone |
8 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
9 | Director North American Sales | Reveal Email/Phone |
10 | Associate Director - Biochemistry / Technology Development | Reveal Email/Phone |
NABsys Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12M | 362 | 6% | $208.1M | N/A |
What Is NABsys?
NABsys aims to make whole-genome DNA sequencing fast, inexpensive, and accurate enough to be used in clinical care. Our approach builds on existing solid-state technologies to create a whole-genome sequencing technology that employs electronic detection, does not depend on a polymerase, and directly obtains DNA sequence information over hundreds of thousands of bases.
keywords:Biotechnology$145M
Total Funding
44
Number of Employees
$2.8M
Revenue (est)
52%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NABsys News
Funding will fuel further development and commercialization of Nabsys' second-generation High-Definition Mapping platform.
A Providence biotech firm has closed on a $25 million equity round in collaboration with a Tokyo electronics giant. Nabsys Inc., a pioneer...
Nabsys, a Providence, RI-based high-definition genome mapping company, closed a $21m equity funding. The round was led by Hitachi High-Technologies Corporation. The company intends to use the funds to finalize product development and support global commercial launch of their HD-Mapping™ whole- ...
Share Share on Facebook Share on Twitter LinkedIn Email Reprints Raising money, shutting down, hiring people and getting acquired—four different entities just about covering all the bases of early stage business and investing news: —NABsys, a Providence, RI-based gene sequencing startup, says ...
Nabsys, Inc., a Providence, RI-based life sciences company developing solid-state, single-molecule positional sequencing with broad applicability in DNA analysis, closed a $20m Series D financing. The round was led by new investor Bay City Capital with participation from existing investors Poin ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 44 | 38% | N/A |
#2 | $5.3M | 44 | 26% | N/A |
#3 | $10.7M | 44 | 7% | N/A |
#4 | $4.6M | 44 | 16% | N/A |
#5 | $11.4M | 44 | 10% | N/A |